Switching associated with initiation of calcitonin gene-related peptide monoclonal antibodies versus non-calcitonin gene-related peptide monoclonal antibodies treatments for prevention of migraine

被引：0
|
作者：
Foster, S. A. [1 ]
Manjelievskaia, J. [2 ]
Ford, J. H. [1 ]
Ye, W. [3 ]
Perry, A. [4 ]
Schuh, K. [1 ]
Wenzel, R. [1 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] IBM Watson Hlth, Armonk, NY USA
[3] Eli Lilly & Co, Indianapolis, IN 46285 USA
[4] IBM Watson Hlth, Roslyn Hts, NY USA
来源：
HEADACHE | 2021年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P-87
引用
收藏
页码：75 / 76
页数：2
相关论文
共 50 条
  • [21] New Trends in Migraine Pharmacology: Targeting Calcitonin Gene-Related Peptide (CGRP) With Monoclonal Antibodies
    Scuteri, Damiana
    Adornetto, Annagrazia
    Rombola, Laura
    Naturale, Maria Diana
    Morrone, Luigi Antonio
    Bagetta, Giacinto
    Tonin, Paolo
    Corasaniti, Maria ziana
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [22] Can calcitonin gene-related peptide monoclonal antibodies ameliorate writer's cramp and migraine?
    Suzuki, Keisuke
    Suzuki, Shiho
    Fujita, Hiroaki
    Sakuramoto, Hirotaka
    Shioda, Mukuto
    Hirata, Koichi
    NEUROPSYCHOPHARMACOLOGY REPORTS, 2024, 44 (02) : 482 - 484
  • [23] Anti-calcitonin Gene-Related Peptide Monoclonal Antibodies in Migraine: Focus on Clinical Pharmacokinetics
    Jankovic, Slobodan M.
    Jankovic, Snezana V.
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2024, 49 (03) : 277 - 293
  • [24] The effect of calcitonin gene-related peptide monoclonal antibodies on restless legs syndrome in patients with migraine
    Suzuki, Keisuke
    Suzuki, Shiho
    Fujita, Hiroaki
    Kobayashi, Saro
    Shioda, Mukuto
    Hida, Ryotaro
    Hirata, Koichi
    JOURNAL OF HEADACHE AND PAIN, 2025, 26 (01):
  • [25] Switching of monoclonal antibodies against calcitonin gene-related peptide in chronic migraine in clinical practice: a case series
    Del Pilar Briceno-Casado, Maria
    David Gil-Sierra, Manuel
    De-la-Calle-Riaguas, Beatriz
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2023, 30 (04)
  • [26] Safety efficacy and tolerability of the calcitonin gene-related peptide monoclonal antibodies for migraine prevention treatment of migraine, Kuwait experience
    Ashkanani, Hasan
    Al-Hashel, Jasem
    Ahmed, Samar
    Alroughani, Raed
    Alwazzan, Sawsan
    NEUROLOGY, 2021, 96 (15)
  • [27] Calcitonin gene-related peptide and migraine
    Ruth Kirby
    Nature Clinical Practice Neurology, 2006, 2 (1): : 5 - 5
  • [28] Calcitonin gene-related peptide and migraine
    Karsan, Nazia
    Goadsby, Peter J.
    CURRENT OPINION IN NEUROLOGY, 2015, 28 (03) : 250 - 254
  • [29] Patient satisfaction with calcitonin gene-related peptide monoclonal antibodies in migraine: A multicenter prospective cohort study
    Lopez-Bravo, Alba
    Minguez-Olaondo, Ane
    Nieves-Castellanos, Candela
    Ruibal-Salgado, Marta
    Sanchez-Mateos, Noemi Morollon
    Navarro-Perez, Maria Pilar
    Alpuente, Alicia
    Torres-Ferrus, Marta
    Garcia-Ull, Jesica
    Gago-Veiga, Ana
    Garcia-Azorin, David
    Gonzalez-Martinez, Alicia
    Sierra, Alvaro
    Santos-Lasaosa, Sonia
    HEADACHE, 2025,
  • [30] Monoclonal antibodies against calcitonin gene-related peptide in chronic migraine: an adjusted indirect treatment comparison
    del Pilar Briceno-Casado, Maria
    David Gil-Sierra, Manuel
    Fenix-Caballero, Silvia
    FARMACIA HOSPITALARIA, 2020, 44 (05) : 212 - 217
12345